At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/OD), during the 'Abeta Targeting Therapies in AD' symposium on 3 April, Roche presented interim trial data for ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Biogen BIIB announced that the FDA has granted fast track designation to its investigational Alzheimer's disease (AD) drug, ...

Strokes caused by an artery tear are landing five times as many Americans in the hospital these days, a new study says.

Roche has reported preliminary results on its Alzheimer’s disease prospect trontinemab. | Roche has reported preliminary ...

Lilly Goldberg ’28 is a first-year pitcher on the Swarthmore softball team. The Pittsford native had a strong performance on ...

Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's ...

Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.

Biopharma leaders react to the forced resignation of CBER Head Peter Marks as RFK Jr.’s promised job cuts begin at the FDA; ...

China continues to boost pharmaceutical innovation through regulatory reforms and as a result, "the pace of new drug ...